Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: The importance of disease heterogeneity

M. Infante, C. Ricordi

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)8702-8704
Number of pages3
JournalEuropean review for medical and pharmacological sciences
Volume23
Issue number19
DOIs
StatePublished - Jan 1 2019

Fingerprint

Type 1 Diabetes Mellitus
Immunotherapy

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{316ef27eb20043759e1e96d0c704b466,
title = "Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: The importance of disease heterogeneity",
author = "M. Infante and C. Ricordi",
year = "2019",
month = "1",
day = "1",
doi = "10.26355/eurrev_201910_19188",
language = "English (US)",
volume = "23",
pages = "8702--8704",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "19",

}

TY - JOUR

T1 - Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes

T2 - The importance of disease heterogeneity

AU - Infante, M.

AU - Ricordi, C.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85074076989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074076989&partnerID=8YFLogxK

U2 - 10.26355/eurrev_201910_19188

DO - 10.26355/eurrev_201910_19188

M3 - Editorial

C2 - 31646605

AN - SCOPUS:85074076989

VL - 23

SP - 8702

EP - 8704

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 19

ER -